Carbocisteine for acute exacerbations of COPD - Authors' reply

The Lancet

Volumn 372, Issue 9650, 2008, Pages 1631-1632

  Zheng, Jin Ping ^a   Zhong, Nan Shan ^a   Jiang, Mei ^a   Zeng, Guang Qiao ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CARBOCISTEINE; CORTICOSTEROID; PLACEBO;

BACTERIUM ADHERENCE; CAUSE OF DEATH; CHI SQUARE TEST; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMMON COLD; DISEASE EXACERBATION; DISEASE MARKER; HUMAN; INFLAMMATION; KAPLAN MEIER METHOD; LETTER; LUNG CANCER; LYMPHOMA; MICROBIAL ADHESION; MORTALITY; PRIORITY JOURNAL; PROBABILITY; RESPIRATORY EPITHELIUM;

EID: 55149105278     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61683-9     Document Type: Letter

References (5)

1. Zheng J.P., Kang J., Huang S.G., et al. Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study. Lancet 371 (2008) 2013-2018
2. Hurst J.R., Donaldson G.C., Wilinson T., Perera W.R., and Wedzicha J.A. Epidemiological relationships between the common cold and exacerbation frequency in COPD. Eur Respir J 26 (2005) 846-852
3. Hurst J.R., Donaldson G.C., Perera W.R., et al. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 174 (2006) 867-874
4. Yasuda H., Yamaya M., Sasaki T., et al. Carbocysteine reduces frequency of common colds and exacerbations in patients with chronic obstructive pulmonary disease. J Am Geriatr Soc 54 (2006) 378-380
5. Cakan G., Turkoz M., Turan T., Ahmed K., and Nagatake T. S-carboxymethylcysteine inhibits the attachment of streptococcus pneumoniae to human pharyngeal epithelial cells. Microb Pathog 34 (2003) 261-265